{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:25:03Z","timestamp":1783455903843,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Danish Agency for Science, Technology and Innovation, Medical Research Council","award":["10-084244"],"award-info":[{"award-number":["10-084244"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ejphar.2014.12.012","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T02:14:54Z","timestamp":1419041694000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Assessment of anti-arrhythmic activity of antipsychotic drugs in an animal model: Influence of non-cardiac \u03b11-adrenergic receptors"],"prefix":"10.1016","volume":"748","author":[{"given":"Tomas","family":"Mow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten B","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.12.012_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiologic basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ejphar.2014.12.012_bib2","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1073\/pnas.85.22.8756","article-title":"Alpha 1-adrenergic agonists selectively suppress voltage-dependent K+ current in rat ventricular myocytes","volume":"85","author":"Apkon","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2014.12.012_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology Off. Publ. Am. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2014.12.012_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/S0007125000298097","article-title":"Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics","author":"Barnes","year":"1999","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.ejphar.2014.12.012_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjp.0704550","article-title":"Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes","volume":"135","author":"Batey","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.171.6.502","article-title":"Excess mortality of schizophrenia. A meta-analysis","volume":"171","author":"Brown","year":"1997","journal-title":"Br. J. Psychiatry J. Ment. Sci"},{"key":"10.1016\/j.ejphar.2014.12.012_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"Buckley","year":"2000","journal-title":"Drug Saf. Int. J. Med. Toxicol. Drug Exp"},{"key":"10.1016\/j.ejphar.2014.12.012_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0008-6363(99)00124-8","article-title":"Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists","volume":"43","author":"Burashnikov","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2008.04.004","article-title":"The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes","volume":"119","author":"Carlsson","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib10","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/cvr\/27.12.2186","article-title":"Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations","volume":"27","author":"Carlsson","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005344-199008000-00014","article-title":"QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions","volume":"16","author":"Carlsson","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3565(25)20959-4","article-title":"Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload","volume":"279","author":"Carlsson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0008-6363(98)00036-4","article-title":"Polymorphic ventricular tachycardias induced by d-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entry","volume":"38","author":"Derakhchan","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bjp.0706203","article-title":"Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes","volume":"145","author":"Detre","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib300","first-page":"263","article-title":"Ventricular tachycardia with 2 variable opposing foci","volume":"59","author":"Dessertenne","year":"1966","journal-title":"Arch. Mal. Coeur. Vaiss."},{"key":"10.1016\/j.ejphar.2014.12.012_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/clc.20945","article-title":"Acquired long QT interval: a case series of multifactorial QT prolongation","volume":"34","author":"Digby","year":"2011","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.300.1.64","article-title":"Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation","volume":"300","author":"Eckardt","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.RES.68.5.1179","article-title":"Myocardial alpha 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium","volume":"68","author":"Endoh","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.vascn.2004.05.002","article-title":"How to measure electrocardiographic QT interval in the anaesthetized rabbit","volume":"50","author":"Farkas","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2014.12.012_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/bjp.2008.154","article-title":"Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model","volume":"154","author":"Farkas","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2006.03.014","article-title":"Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts","volume":"537","author":"Farkas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1113\/jphysiol.1991.sp018772","article-title":"Alpha 1-adrenoceptors reduce background K+ current in rabbit ventricular myocytes","volume":"441","author":"Fedida","year":"1991","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","article-title":"Drug-induced torsades de pointes and implications for drug development","volume":"15","author":"Fenichel","year":"2004","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(79)90202-4","article-title":"Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors","volume":"55","author":"Greengrass","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib25","doi-asserted-by":"crossref","first-page":"s64","DOI":"10.1192\/bjp.191.50.s64","article-title":"Adverse effects of antipsychotics as outcome measures","volume":"50","author":"Hamer","year":"2007","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.ejphar.2014.12.012_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","article-title":"A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition","volume":"24","author":"Harrigan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the european society of cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/13651500215969","article-title":"Sertindole: cardiac electrophysiological profile","volume":"6","author":"Haverkamp","year":"2002","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ejphar.2014.12.012_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/aps.2010.210","article-title":"Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1","volume":"32","author":"Ji","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2014.12.012_bib30","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting Torsade de Pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep"},{"key":"10.1016\/j.ejphar.2014.12.012_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00392-008-0741-y","article-title":"Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors","volume":"98","author":"Letsas","year":"2009","journal-title":"Clin. Res. Cardiol. Off. J. Ger. Card. Soc"},{"key":"10.1016\/j.ejphar.2014.12.012_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vph.2014.06.003","article-title":"Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats","volume":"62","author":"Leung","year":"2014","journal-title":"Vascul. Pharmacol"},{"key":"10.1016\/j.ejphar.2014.12.012_bib33","doi-asserted-by":"crossref","first-page":"rs11","DOI":"10.1126\/scisignal.2003506","article-title":"In vivo phosphoproteomics analysis reveals the cardiac targets of \u03b2-adrenergic receptor signaling","volume":"6","author":"Lundby","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2014.12.012_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ncb1218","article-title":"TRPC1 forms the stretch-activated cation channel in vertebrate cells","volume":"7","author":"Maroto","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2011.01558.x","article-title":"Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes","volume":"165","author":"Nalos","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/11587800-000000000-00000","article-title":"Assessing QT interval prolongation and its associated risks with antipsychotics","volume":"25","author":"Nielsen","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2014.12.012_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-007-1064-9","article-title":"Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function","volume":"199","author":"Nourian","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2014.12.012_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-007-1064-9","article-title":"Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function","volume":"199","author":"Nourian","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2014.12.012_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2008.08.014","article-title":"The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human alpha1A1-adrenoceptors","volume":"596","author":"Nourian","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2008.03.006","article-title":"The canine model with chronic, complete atrio-ventricular block","volume":"119","author":"Oros","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib41","doi-asserted-by":"crossref","first-page":"e81208","DOI":"10.1371\/journal.pone.0081208","article-title":"Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe","volume":"8","author":"Raschi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.12.012_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCEP.113.000223","article-title":"Influence of intracardiac pressure on spontaneous ventricular arrhythmias in patients with systolic heart failure: insights from the REDUCEhf trial","volume":"6","author":"Reiter","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol"},{"issue":"Suppl. 10","key":"10.1016\/j.ejphar.2014.12.012_bib43","first-page":"5","article-title":"Receptor pharmacology of neuroleptics: relation to clinical effects","volume":"60","author":"Richelson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.12.012_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1540-8167.2000.tb00739.x","article-title":"Ionic basis for action potential prolongation by phenylephrine in canine epicardial myocytes","volume":"11","author":"Robinson","year":"2000","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881113515064","article-title":"Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics","volume":"28","author":"Silvestre","year":"2014","journal-title":"J. Psychopharmacol. Oxf. Engl"},{"key":"10.1016\/j.ejphar.2014.12.012_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004714-199710000-00011","article-title":"Two rapid-dose titrations of sertindole in patients with schizophrenia","volume":"17","author":"Sramek","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-200022030-00004","article-title":"Tolerability of atypical antipsychotics","volume":"22","author":"Stanniland","year":"2000","journal-title":"Drug Saf. Int. J. Med. Toxicol. Drug Exp"},{"key":"10.1016\/j.ejphar.2014.12.012_bib48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00424-005-1492-5","article-title":"Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels","volume":"451","author":"Takahira","year":"2005","journal-title":"Pfl\u00fcg. Arch. Eur. J. Physiol"},{"key":"10.1016\/j.ejphar.2014.12.012_bib49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2005.04.009","article-title":"Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias","volume":"112","author":"Thomsen","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hrthm.2008.11.023","article-title":"Deleting the accessory subunit KChIP2 results in loss of I(to,f) and increased I(K,slow) that maintains normal action potential configuration","volume":"6","author":"Thomsen","year":"2009","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ejphar.2014.12.012_bib51","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000145162.64183.C8","article-title":"Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs","volume":"110","author":"Thomsen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.12.012_bib52","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2006.05.048","article-title":"Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes","volume":"48","author":"Thomsen","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/jpet.103.052753","article-title":"Electrophysiological safety of sertindole in dogs with normal and remodeled hearts","volume":"307","author":"Thomsen","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jelectrocard.2010.05.014","article-title":"Models of stretch-activated ventricular arrhythmias","volume":"43","author":"Trayanova","year":"2010","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.mehy.2007.06.030","article-title":"Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1","volume":"70","author":"Tsai","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2014.12.012_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bjp.0707536","article-title":"Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits","volume":"153","author":"Vincze","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.12.012_bib57","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0008-6363(96)00270-2","article-title":"Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes","volume":"34","author":"Volders","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.12.012_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0163-7258(01)00162-0","article-title":"Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias","volume":"92","author":"Vos","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.12.012_bib59","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.108.137729","article-title":"Antitorsadogenic effects of ({+\/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits","volume":"325","author":"Wang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400870X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400870X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:00:49Z","timestamp":1747238449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400870X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":60,"alternative-id":["S001429991400870X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.12.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of anti-arrhythmic activity of antipsychotic drugs in an animal model: Influence of non-cardiac \u03b11-adrenergic receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}